Cardiovascular Systems Inc 4
4 · Cardiovascular Systems Inc · Filed Sep 9, 2016
Insider Transaction Report
Form 4
Koehn Paul A
VP of Manufacturing
Transactions
- Sale
Common Stock
2016-09-07$25.02/sh−5,969$149,368→ 79,290 total - Exercise/Conversion
Stock Option (right to buy)
2016-09-07−4,675→ 30,910 totalExercise: $8.83Exp: 2017-04-17→ Common Stock (4,675 underlying) - Exercise/Conversion
Stock Option (right to buy)
2016-09-07−1,294→ 0 totalExercise: $8.83Exp: 2017-04-17→ Common Stock (1,294 underlying) - Exercise/Conversion
Common Stock
2016-09-07$8.83/sh+5,969$52,706→ 73,321 total
Holdings
- 32,350
Stock Option (right to buy)
Exercise: $12.15Exp: 2017-12-11→ Common Stock (32,350 underlying) - 8,087
Stock Option (right to buy)
Exercise: $7.90Exp: 2017-06-11→ Common Stock (8,087 underlying) - 12,940
Stock Option (right to buy)
Exercise: $7.90Exp: 2017-10-08→ Common Stock (12,940 underlying) - 8,087
Stock Option (right to buy)
Exercise: $8.75Exp: 2019-03-01→ Common Stock (8,087 underlying)
Footnotes (3)
- [F1]Fully exercisable.
- [F2]The option exercise and sales of the underlying shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.22 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.